Ma C, Ma X, Jiang B, Pan H, Liao X, Zhang L
Signal Transduct Target Ther. 2021; 6(1):353.
PMID: 34593766
PMC: 8484301.
DOI: 10.1038/s41392-021-00752-8.
Sainz-Mejias M, Jurado-Martin I, McClean S
Cells. 2020; 9(12).
PMID: 33291484
PMC: 7762141.
DOI: 10.3390/cells9122617.
Gholami M, Chirani A, Falak R, Moshiri M, Razavi S, Irajian G
Rep Biochem Mol Biol. 2018; 7(1):38-44.
PMID: 30324116
PMC: 6175586.
Allison T, Conrad S, Castric P
Microbiology (Reading). 2015; 161(9):1780-1789.
PMID: 26297472
PMC: 4635471.
DOI: 10.1099/mic.0.000128.
Tan R, Kuang Z, Hao Y, Lee F, Lee T, Lee R
Infect Immun. 2015; 83(4):1339-46.
PMID: 25605768
PMC: 4363409.
DOI: 10.1128/IAI.02874-14.
The sweet tooth of bacteria: common themes in bacterial glycoconjugates.
Tytgat H, Lebeer S
Microbiol Mol Biol Rev. 2014; 78(3):372-417.
PMID: 25184559
PMC: 4187687.
DOI: 10.1128/MMBR.00007-14.
Type IV pilin proteins: versatile molecular modules.
Giltner C, Nguyen Y, Burrows L
Microbiol Mol Biol Rev. 2012; 76(4):740-72.
PMID: 23204365
PMC: 3510520.
DOI: 10.1128/MMBR.00035-12.
Recent developments for Pseudomonas vaccines.
Sharma A, Krause A, Worgall S
Hum Vaccin. 2011; 7(10):999-1011.
PMID: 21941090
PMC: 3360073.
DOI: 10.4161/hv.7.10.16369.
Glycosylation of pilin and nonpilin protein constructs by Pseudomonas aeruginosa 1244.
Qutyan M, Henkel M, Horzempa J, Quinn M, Castric P
J Bacteriol. 2010; 192(22):5972-81.
PMID: 20833803
PMC: 2976441.
DOI: 10.1128/JB.00007-10.
Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.
Horzempa J, Held T, Cross A, Furst D, Qutyan M, Neely A
Clin Vaccine Immunol. 2008; 15(4):590-7.
PMID: 18272666
PMC: 2292668.
DOI: 10.1128/CVI.00476-07.
Functional consequences of sequence variation in bundlin, the enteropathogenic Escherichia coli type IV pilin protein.
Fernandes P, Guo Q, Donnenberg M
Infect Immun. 2007; 75(10):4687-96.
PMID: 17635860
PMC: 2044524.
DOI: 10.1128/IAI.00009-07.
Influence of pilin glycosylation on Pseudomonas aeruginosa 1244 pilus function.
Smedley 3rd J, Jewell E, Roguskie J, Horzempa J, Syboldt A, Stolz D
Infect Immun. 2005; 73(12):7922-31.
PMID: 16299283
PMC: 1307089.
DOI: 10.1128/IAI.73.12.7922-7931.2005.
Glycosylation substrate specificity of Pseudomonas aeruginosa 1244 pilin.
Horzempa J, Comer J, Davis S, Castric P
J Biol Chem. 2005; 281(2):1128-36.
PMID: 16286455
PMC: 2248725.
DOI: 10.1074/jbc.M510975200.
Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells.
Hsieh J, Tham D, Feng W, Huang F, Embaie S, Liu K
Infect Immun. 2005; 73(11):7705-17.
PMID: 16239575
PMC: 1273878.
DOI: 10.1128/IAI.73.11.7705-7717.2005.
Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site.
Comer J, Marshall M, Blanch V, Deal C, Castric P
Infect Immun. 2002; 70(6):2837-45.
PMID: 12010970
PMC: 128005.
DOI: 10.1128/IAI.70.6.2837-2845.2002.
Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells.
Schroeder T, Zaidi T, Pier G
Infect Immun. 2001; 69(2):719-29.
PMID: 11159960
PMC: 97944.
DOI: 10.1128/IAI.69.2.719-729.2001.
Analysis of the type IV fimbrial-subunit gene fimA of Xanthomonas hyacinthi: application in PCR-mediated detection of yellow disease in Hyacinths.
van Doorn J, Hollinger T, Oudega B
Appl Environ Microbiol. 2001; 67(2):598-607.
PMID: 11157222
PMC: 92626.
DOI: 10.1128/AEM.67.2.598-607.2001.
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers.
Sajjan U, Sun L, Goldstein R, Forstner J
J Bacteriol. 1995; 177(4):1030-8.
PMID: 7532166
PMC: 176699.
DOI: 10.1128/jb.177.4.1030-1038.1995.